LENSAR Inc (LNSR)
6.06
+0.20
(+3.41%)
USD |
NASDAQ |
Nov 05, 09:35
LENSAR Revenue (Quarterly): 12.64M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 12.64M |
| March 31, 2024 | 10.59M |
| December 31, 2023 | 12.10M |
| September 30, 2023 | 9.795M |
| June 30, 2023 | 12.01M |
| March 31, 2023 | 8.252M |
| December 31, 2022 | 10.23M |
| September 30, 2022 | 7.748M |
| June 30, 2022 | 8.038M |
| March 31, 2022 | 9.34M |
| Date | Value |
|---|---|
| December 31, 2021 | 11.22M |
| September 30, 2021 | 8.272M |
| June 30, 2021 | 7.922M |
| March 31, 2021 | 7.043M |
| December 31, 2020 | 8.284M |
| September 30, 2020 | 7.145M |
| June 30, 2020 | 5.047M |
| March 31, 2020 | 5.906M |
| December 31, 2019 | 8.46M |
| September 30, 2019 | 8.068M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
5.047M
Minimum
Jun 2020
12.64M
Maximum
Jun 2024
8.950M
Average
8.284M
Median
Dec 2020
Revenue (Quarterly) Benchmarks
| Standard BioTools Inc | 44.97M |
| Ainos Inc | -- |
| Zomedica Corp | 6.131M |
| Intelligent Bio Solutions Inc | 0.7278M |
| Adagio Medical Holdings Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.043M |
| Total Expenses (Quarterly) | 14.19M |
| EPS Diluted (Quarterly) | -0.79 |
| Enterprise Value | 53.81M |
| Gross Profit Margin (Quarterly) | 53.92% |
| Profit Margin (Quarterly) | -71.57% |
| Earnings Yield | -25.74% |
| Normalized Earnings Yield | -18.41 |